First Cancer Patient Treated with Varian ProBeam Compact Proton Therapy System at Treatment ...
PALO ALTO, Calif., Nov. 18, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute (SFPTI), a Proton International facility, on the campus of Delray Medical Center, has treated its first patient utilizing the Varian ProBeam® Compact single-room proton therapy system. Proton therapy can be used to treat many types of tumors including in the brain, head and neck, central nervous system and lung, and more precisely targets cancer cells...This story is related to the following:Radiotherapy Systems (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - November 19, 2019 Category: Medical Devices Source Type: news
Cancer Center Aims to Evaluate Proton Therapy in NSCLC
Proton therapy ’s direct and precise application of radiation for mid-stage lung cancer is being investigated in an ongoing phase III trial at the University of Cincinnati. (Source: CancerNetwork)
Source: CancerNetwork - November 7, 2019 Category: Cancer & Oncology Authors: Seth Augenstein Source Type: news
Miami Cancer Institute Begins Using Novel Treatment for Mesothelioma
The Miami Cancer Institute on Thursday will begin using the innovative Tumor Treating Fields device for patients with malignant pleural mesothelioma.
It is the first new treatment approved for mesothelioma by the U.S. Food and Drug Administration in more than 15 years.
“This is actually pretty exciting for us,” Dr. Rupesh Kotecha, the radiation oncologist who will oversee the treatment protocol in Miami, told The Mesothelioma Center at Asbestos.com. “It’s another tool in our armamentarium. It’s something we can offer patients that has shown a real benefit.”
The noninvasive Tumor Treating Fields device works by ...
Source: Asbestos and Mesothelioma News - November 6, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news
Varian ProBeam 360 Proton Therapy System Selected by Penn Medicine for Use in Second Treatment ...
Palo Alto, Calif., Oct. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has been selected by Penn Medicine to install a Varian ProBeam® 360° proton therapy system in a single-room configuration at Lancaster General Health Ann B. Barshinger Cancer Institute in south central Pennsylvania. In addition to the equipment, Varian will also provide its ARIA® information management system and Eclipse™ treatment planning system. Construction of the...This story is related to the following:Electrotherapy Equipment (Source: Industrial Newsroom - Healt...
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 25, 2019 Category: Medical Devices Source Type: news
$48M Penn Medicine proton therapy center coming to Lancaster
Penn Medicine Lancaster General Health has started construction of a $48 million proton therapy center.
The proton therapy center, part of Lancaster General Health's Ann B. Barshinger Cancer Institute, will be the second site in Pennsylvania to offer the high-tech form of radiation therapy to cancer patients when it opens in the fall of 2021.
The first proton therapy center in Pennsylvania opened a t Penn, in a 75,000-square-foot building that is part of the Abramson Cancer Center, in 2010. Penn… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 16, 2019 Category: Pharmaceuticals Authors: John George Source Type: news
$48M Penn Medicine proton therapy center coming to Lancaster
Penn Medicine Lancaster General Health has started construction of a $48 million proton therapy center.
The proton therapy center, part of Lancaster General Health's Ann B. Barshinger Cancer Institute, will be the second site in Pennsylvania to offer the high-tech form of radiation therapy to cancer patients when it opens in the fall of 2021.
The first proton therapy center in Pennsylvania opened a t Penn, in a 75,000-square-foot building that is part of the Abramson Cancer Center, in 2010. Penn… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 16, 2019 Category: Biotechnology Authors: John George Source Type: news
Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical ...
PALO ALTO, Calif., Oct. 14, 2019 /PRNewswire/ -- Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant milestone in the path towards clinical trials of FLASH therapy*. The combined research team utilized a Varian ProBeam® proton therapy gantry treatment room in research mode to successfully complete a FLASH delivery to a phantom target. This...This story is related to the following:Radiotherapy Systems | (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 15, 2019 Category: Medical Devices Source Type: news
Children ’s, UC Health hit milestone in 1-second cancer treatment
The Proton Therapy Center operated by Cincinnati Children ’s Hospital and UC Health has hit a significant milestone in researching the use of high doses of proton beams delivered at ultra-high speeds to treat cancer.
The advancement in so-called flash therapy, which is delivered in one to three sessions that each last less than one second, is a step tow ard clinical trials.
Equipment maker Varian Medical Systems of Palo Alto, Calif., has been researching the value of such ultra-high-dose-rate proton… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 14, 2019 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news
IBA and CAMH partner to build nuclear medicine program
Proton therapy developer Ion Beam Applications (IBA) and Azrieli Centre for...Read more on AuntMinnie.comRelated Reading:
IBA takes next step in China deal
IBA to install carbon therapy in France
IBA posts revenue increase in 1st half of 2019
IBA inks deal to install cyclotron in South Korea
IBA takes order from Kan. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 11, 2019 Category: Radiology Source Type: news
FDA clears ProTom's Radiance proton therapy system
The U.S. Food and Drug Administration (FDA) has cleared proton therapy developer...Read more on AuntMinnie.comRelated Reading:
ProTom files for bankruptcy protection
ProTom begins installing synchrotron
Proton therapy experts look back and to the future
ProTom, MIT test accelerator (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 7, 2019 Category: Radiology Source Type: news
ProTom Receives U.S. FDA 510(k) Clearance for Its Radiance 330(R) Single Room Proton Therapy System
WAKEFIELD, Mass., Oct. 7, 2019 -- (Healthcare Sales & Marketing Network) -- ProTom International Holding Corporation ("ProTom"), a market-leading proton therapy technology manufacturer, announced that it has received 510(k) clearance from the U.... Devices, Oncology, FDA ProTom International, Radiance 330, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 7, 2019 Category: Pharmaceuticals Source Type: news
IBA takes next step in China deal
Proton therapy developer Ion Beam Applications (IBA) has taken a down payment...Read more on AuntMinnie.comRelated Reading:
IBA to install carbon therapy in France
IBA posts revenue increase in 1st half of 2019
IBA inks deal to install cyclotron in South Korea
IBA takes order from Kan.
NorthStar to buy IBA accelerators for Mo-99 production (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 1, 2019 Category: Radiology Source Type: news
New Proton Therapy System Offers Clinical Capabilities with up to 30% Small Footprint
ProBeam 360° system allows cancer centers to tailor the system to meet their clinical, research, and capacity needs Treatment room options include 360-degree rotating gantries, and fixed beam rooms Provide clinicians a viable path to potential next-generation treatments such as FLASH therapyThis story is related to the following:Clinical Medical Equipment (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - September 17, 2019 Category: Medical Devices Source Type: news
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
PALO ALTO, Calif., Sept. 16, 2019 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is the smallest multi-... Devices, Oncology, Product Launch Varian Medical Systems, ProBeam, ProBeam 360, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 16, 2019 Category: Pharmaceuticals Source Type: news
New studies laud benefits of proton therapy for kids
Children with cancer who are treated with proton therapy had better outcomes...Read more on AuntMinnie.comComments:
9/12/2019 8:09:08 AMAdmin
hgjghjhjfjfgg (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 12, 2019 Category: Radiology Source Type: news
